Interpace Biosciences, Inc.
IDXG
$1.25
$0.00280.23%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 4.70M | 2.81M | 919.00K | 802.00K | -1.65M |
| Total Depreciation and Amortization | 1.18M | 1.35M | 1.73M | 2.06M | 2.71M |
| Total Amortization of Deferred Charges | 0.00 | 14.00K | 28.00K | 42.00K | 57.00K |
| Total Other Non-Cash Items | 1.06M | 999.00K | 1.36M | 1.43M | 2.46M |
| Change in Net Operating Assets | -2.34M | -1.58M | -1.43M | -544.00K | -1.21M |
| Cash from Operations | 4.60M | 3.59M | 2.60M | 3.79M | 2.37M |
| Capital Expenditure | -889.00K | -519.00K | -433.00K | -470.00K | -524.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 500.00K | 383.00K | 383.00K | -520.00K |
| Cash from Investing | -889.00K | -19.00K | -50.00K | -87.00K | -1.04M |
| Total Debt Issued | -- | -- | -- | -- | 0.00 |
| Total Debt Repaid | -4.10M | -4.10M | -2.80M | -2.50M | -2.50M |
| Issuance of Common Stock | -- | -- | -- | -- | 2.00K |
| Repurchase of Common Stock | -32.00K | -32.00K | -32.00K | -32.00K | -108.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.50M | -2.50M | -2.50M | -2.50M | -- |
| Cash from Financing | -6.63M | -6.63M | -5.33M | -5.03M | -2.61M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.92M | -3.06M | -2.78M | -1.33M | -1.28M |
